|
Market Cap (24-Jun) $110,470,648 (1,377th) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 622,600 |
Shortsold (30-Dec) 421 (0.00%) (625th) |
|
52w High $1.44 |
52w Low $0.225 |
P/E - |
EPS -0.02 |
NYR released this announcement to the ASX on 24 February 2023, 10:44. The announcement is marked as price sensitive, and is 20 page(s) in length and 774.49kb in size.
You can view all announcements from NYR and see how they appear on a price chart on the announcements page.
At the date of this announcement, NYR was 0.001% short sold according to ASIC data. It was ranked the 633rd most shorted stock on the ASX. It is now ranked as the 625th most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (30 December 2025).
| Other Recent Announcements from NYR | |
|---|---|
| Cholesterol-Lowering Program Update | 26 June 2023, 9:55 |
| Brain Injury Program Preclinical Development Update | 9 June 2023, 8:18 |
| Cholesterol-Lowering Program Preclinical Studies Completed | 26 May 2023, 8:44 |
| Appendix 4D and Half Year Report to 31 December 2022 | 24 February 2023, 10:44 |
| Quarterly Activities Report and Appendix 4C | 30 January 2023, 8:26 |
| Collaboration with Walter Reed and UNSW Extended to 2025 | 18 January 2023, 8:35 |
| Notification of cessation of securities - NYR | 16 January 2023, 16:24 |
You must be logged in to post a reply.
Nyrada Inc 